IT1163944B - 2-SUBSTITUTED CARBAPENEM DERIVATIVE ANTIBIOTICS AND RELATED PREPARATION PROCEDURE - Google Patents

2-SUBSTITUTED CARBAPENEM DERIVATIVE ANTIBIOTICS AND RELATED PREPARATION PROCEDURE

Info

Publication number
IT1163944B
IT1163944B IT23022/83A IT2302283A IT1163944B IT 1163944 B IT1163944 B IT 1163944B IT 23022/83 A IT23022/83 A IT 23022/83A IT 2302283 A IT2302283 A IT 2302283A IT 1163944 B IT1163944 B IT 1163944B
Authority
IT
Italy
Prior art keywords
preparation procedure
carbapenem derivative
related preparation
substituted carbapenem
antibiotics
Prior art date
Application number
IT23022/83A
Other languages
Italian (it)
Other versions
IT8323022A0 (en
Inventor
Un Kim Choung
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of IT8323022A0 publication Critical patent/IT8323022A0/en
Application granted granted Critical
Publication of IT1163944B publication Critical patent/IT1163944B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/26—Radicals substituted by sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/06—1,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65611—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system (X = CH2, O, S, NH) optionally with an additional double bond and/or substituents, e.g. penicillins and analogs
IT23022/83A 1982-09-28 1983-09-27 2-SUBSTITUTED CARBAPENEM DERIVATIVE ANTIBIOTICS AND RELATED PREPARATION PROCEDURE IT1163944B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42575582A 1982-09-28 1982-09-28
US53001183A 1983-09-09 1983-09-09

Publications (2)

Publication Number Publication Date
IT8323022A0 IT8323022A0 (en) 1983-09-27
IT1163944B true IT1163944B (en) 1987-04-08

Family

ID=27026797

Family Applications (1)

Application Number Title Priority Date Filing Date
IT23022/83A IT1163944B (en) 1982-09-28 1983-09-27 2-SUBSTITUTED CARBAPENEM DERIVATIVE ANTIBIOTICS AND RELATED PREPARATION PROCEDURE

Country Status (29)

Country Link
KR (1) KR890002228B1 (en)
AR (1) AR241785A1 (en)
AT (1) AT382621B (en)
AU (1) AU575541B2 (en)
CA (1) CA1269978A (en)
CH (1) CH656130A5 (en)
CS (1) CS247168B2 (en)
DD (1) DD212255A5 (en)
DE (1) DE3334937A1 (en)
DK (1) DK442383A (en)
ES (1) ES525983A0 (en)
FI (1) FI78094C (en)
FR (1) FR2533568B1 (en)
GB (1) GB2128187B (en)
GR (1) GR78696B (en)
HU (1) HU191066B (en)
IE (1) IE55947B1 (en)
IL (1) IL69824A (en)
IT (1) IT1163944B (en)
LU (1) LU85021A1 (en)
NL (1) NL8303310A (en)
NO (1) NO163284C (en)
NZ (1) NZ205626A (en)
OA (1) OA07548A (en)
PT (1) PT77404B (en)
SE (1) SE461734B (en)
SU (1) SU1493108A3 (en)
YU (1) YU43196B (en)
ZW (1) ZW20783A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683296A (en) * 1983-03-07 1987-07-28 Bristol-Myers Company Carbapenem intermediates
CA1273011A (en) * 1984-07-02 1990-08-21 Susan M. Schmitt Carbapenems having an externally alkylated mono- or bicyclic 2-quaternary heteroarylalkylthio substituent
CA1273012A (en) * 1984-07-02 1990-08-21 Burton G. Christensen 1-methylcarbapenems having an externally alkylated mono- of bicyclic 2-quarternary heteroarylalkylthio substituent
US4680292A (en) * 1984-12-13 1987-07-14 Merck & Co., Inc. Carbapenems and 1-methylcarbapenems having a 2-heteroaryliumaliphatic substituent
US4725594A (en) * 1984-12-13 1988-02-16 Merck & Co., Inc. Carbapenems having an internally or externally alkylated mono- or bicyclic 2-quaternary heteroarylalxyl heteromethyl substituent
US4729993A (en) * 1984-12-13 1988-03-08 Merck & Co., Inc. Carbapenems and 1-methylcarbapenems having an externally alkylated mono- or bicyclic 2-quaternary heteroarylalkyl substituent
US4665169A (en) * 1985-09-11 1987-05-12 Bristol-Myers Company Carbapenem antibiotics
US4880922A (en) * 1985-11-22 1989-11-14 Bristol-Myers Company Carbapenems with quaternized heterothioalkylthio substitution at position 2
NZ219892A (en) * 1986-04-15 1991-02-26 Merck & Co Inc N-amino quaternised heteroarylium carbapenem derivatives and pharmaceutical compositions thereof
DK168047B1 (en) * 1987-12-07 1994-01-24 Lederle Japan Ltd (1R, 5S, 6S) -2-SUBSTITUTED THIO-6-OE (R) -1-HYDROXYETHYLAA-1-METHYL-CARBAPENEM-3-CARBOXYLIC ACID DERIVATIVES, PROCEDURES FOR PREPARING THEREOF, MIXTURES AND PREPARATION
EP0876370A1 (en) 1996-01-12 1998-11-11 Takeda Chemical Industries, Ltd. Carbapenem compounds, their production and use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0017992A1 (en) * 1979-04-19 1980-10-29 Merck & Co. Inc. 2-Substituted-6-substituted-1-carbadethiapen-2-em-3-carboxylic acids, processes for preparing them, antibiotic pharmaceutical compositions containing same and process for preparing intermediates
IE52147B1 (en) * 1980-03-27 1987-07-08 Merck & Co Inc 4-(3-carboxy-2-oxopropyl)-azetidin-2-ones and process for their preparation
EP0038869A1 (en) * 1980-04-30 1981-11-04 Merck & Co. Inc. Process for the preparation of 1-carbapenems, and intermediates for their preparation
PT73791B (en) * 1980-10-17 1983-10-14 Merck & Co Inc Process for preparing 2-carbamimidoyl-6-substituted-1- -carbadethiapen-2-em-3-carboxylic acids
GB2089340B (en) * 1980-10-25 1984-09-19 Beecham Group Ltd -lactam antibiotics their preparation and their use
US4552873A (en) * 1981-08-19 1985-11-12 Sankyo Company Limited Carbapenem compounds, and compositions containing them
EP0074599A1 (en) * 1981-09-09 1983-03-23 Takeda Chemical Industries, Ltd. 5,6-cis-Carbapenem derivatives, their production and use

Also Published As

Publication number Publication date
NZ205626A (en) 1986-12-05
LU85021A1 (en) 1984-04-24
DK442383D0 (en) 1983-09-27
SE8305217L (en) 1984-03-29
ZW20783A1 (en) 1984-11-28
IL69824A0 (en) 1983-12-30
DE3334937C2 (en) 1991-05-02
GB8325744D0 (en) 1983-10-26
DK442383A (en) 1984-03-29
ATA344983A (en) 1986-08-15
NO163284C (en) 1990-05-02
AT382621B (en) 1987-03-25
FI833417A0 (en) 1983-09-23
DD212255A5 (en) 1984-08-08
GR78696B (en) 1984-09-27
ES8503354A1 (en) 1985-02-16
KR890002228B1 (en) 1989-06-24
FI833417A (en) 1984-03-29
HU191066B (en) 1987-01-28
IE55947B1 (en) 1991-02-27
FR2533568A1 (en) 1984-03-30
FI78094B (en) 1989-02-28
SU1493108A3 (en) 1989-07-07
OA07548A (en) 1985-03-31
IL69824A (en) 1991-04-15
NO833479L (en) 1984-03-29
CS247168B2 (en) 1986-12-18
SE461734B (en) 1990-03-19
GB2128187B (en) 1986-06-18
AU1934283A (en) 1984-04-05
YU43196B (en) 1989-04-30
SE8305217D0 (en) 1983-09-27
CA1269978A (en) 1990-06-05
DE3334937A1 (en) 1984-04-05
YU190683A (en) 1985-10-31
IE832266L (en) 1984-03-28
FI78094C (en) 1989-06-12
AR241785A1 (en) 1992-12-30
ES525983A0 (en) 1985-02-16
KR840006249A (en) 1984-11-22
GB2128187A (en) 1984-04-26
NL8303310A (en) 1984-04-16
CH656130A5 (en) 1986-06-13
IT8323022A0 (en) 1983-09-27
PT77404B (en) 1986-06-26
FR2533568B1 (en) 1990-01-26
AU575541B2 (en) 1988-08-04
NO163284B (en) 1990-01-22
PT77404A (en) 1983-10-01

Similar Documents

Publication Publication Date Title
IT1178268B (en) INDOLATION DERIVATIVES, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM RELATED PREPARATION AND APPLICATION PROCEDURE
IT8221182A0 (en) CEPHALOSPORIN DERIVATIVES AND PROCEDURE FOR THEIR PREPARATION.
IT1141057B (en) DEFORMYLTYLOSINE DERIVATIVES AND THEIR PREPARATION
IT1140976B (en) ALCHYL-KETOESOPYRANOSIDES DERIVATIVES
IT1163944B (en) 2-SUBSTITUTED CARBAPENEM DERIVATIVE ANTIBIOTICS AND RELATED PREPARATION PROCEDURE
IT1170307B (en) CEPHALOSPORINIC DERIVATIVES AND PROCEDURE FOR THEIR PREPARATION
IT1205272B (en) ERGOLINIC DERIVATIVES
IT1140974B (en) VINYL-3 Cephalosporins DERIVATIVES, AND THEIR PREPARATION
IT1203608B (en) PROLINA DERIVATIVES
IT1231238B (en) AMIDIDIC DERIVATIVES
IT1178465B (en) PROCEDURE FOR THE PREPARATION OF CARBAPENEM DERIVATIVES
IT1175924B (en) CEFEM DERIVATIVES AND PROCEDURES FOR THEIR PREPARATION
IT1215630B (en) ERGOLINA DERIVATIVES.
IT1132403B (en) ALOVINCAMONE DERIVATIVES AND PROCEDURE FOR THEIR PREPARATION
IT8322629A0 (en) DERIVATIVES OF BENZAMIDIES.
IT1164218B (en) ALETEIN DERIVATIVES
IT1131195B (en) BENZODIAZEPINE DERIVATIVES
IT1135629B (en) N-IMIDZOLIL 1-CHROMANE DERIVATIVES AND PROCEDURE FOR THEIR PREPARATION
IT1132404B (en) 10-ALO-E-OMOEBURNANO DERIVATIVES AND PROCEDURE FOR THEIR PREPARATION
IT8419778A0 (en) DERIVATIVES OF BENZAMIDIES.
IT1179577B (en) HALOGENOBENZOPHENONYXIDE DERIVATIVES USED IN PARTICULAR AS ANTIBACTERIAL DRUGS
IT1163847B (en) ANTI-CANCER ANTIBIOTIC AND RELATED PREPARATION PROCEDURE
IT1167707B (en) PHENOXYLANE DERIVATIVES AND RELATED PREPARATION PROCEDURES
IT1183330B (en) PHENYLPROPARGYLAMINE DERIVATIVES
IT8123213A0 (en) TETRAHYDROQUINOL DERIVATIVES